Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001204459-12-000987
Filing Date
2012-05-08
Accepted
2012-05-08 12:46:37
Documents
9
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 208872
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 6763
3 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 2270
  Complete submission text file 0001204459-12-000987.txt   1518035

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT alrx-20120331.xml EX-101.INS 133236
5 XBRL TAXONOMY EXTENSION SCHEMA alrx-20120331.xsd EX-101.SCH 15926
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alrx-20120331_cal.xml EX-101.CAL 30854
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alrx-20120331_def.xml EX-101.DEF 112196
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE alrx-20120331_lab.xml EX-101.LAB 141466
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alrx-20120331_pre.xml EX-101.PRE 123180
Mailing Address 168 KONRAD CRESCENT SUITE 200 MARKHAM A6 V6E2K3
Business Address 168 KONRAD CRESCENT SUITE 200 MARKHAM A6 V6E2K3 (905) 479-3245
ALPHARX INC (Filer) CIK: 0001114936 (see all company filings)

EIN.: 980177440 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-30813 | Film No.: 12820530
SIC: 2834 Pharmaceutical Preparations